Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia. The activity of the protein, which is found in both the brain and blood, affects neural connections in human brains and is uniquely imbalanced in people diagnosed with the condition. The study was an international collaboration recently published in PNAS.

An international research group, led by Jamey Marth, Ph.D., has shown that the neuraminidase 3 enzyme is responsible for the onset and progression of colitis—a chronic digestive disease caused by inflammation of the colon. The study findings, recently published in PNAS, represent a scientific advance toward a targeted therapy to help the millions of people worldwide affected by the disorder. Recurrent infections of Salmonella, a common food poisoning pathogen, can lead to colitis.

Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. However, the treatment doesn’t work for everyone. Hear from scientists on the leading edge of immunotherapy research on how we are making immunotherapy work to improve outcomes for more people living with cancer.

Sanford Burnham Prebys partnered with the Lawrence Family Jewish Community Center in La Jolla to share some of the latest research in women's health topics.

At Sanford Burnham Prebys, we're passionate about finding bold new ways to treat disease, and we recognize the importance of sharing our discoveries with the public—especially during this unprecedented time. Find out where and when you can "meet" our scientists virtually and learn about their research in this community event calendar.